(0.33%) 5 116.86 points
(0.30%) 38 355 points
(0.37%) 15 987 points
(-0.87%) $83.12
(5.77%) $2.03
(0.46%) $2 358.00
(0.46%) $27.66
(3.90%) $958.10
(-0.22%) $0.933
(-0.38%) $10.98
(-0.54%) $0.796
(1.66%) $93.40
3 days till quarter result
(amc 2024-05-02)
Expected move: +/- 6.08%
Live Chart Being Loaded With Signals
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products...
Stats | |
---|---|
本日の出来高 | 18 466.00 |
平均出来高 | 37 220.00 |
時価総額 | 77.34M |
EPS | $0.100 ( 2024-02-01 ) |
次の収益日 | ( $0.160 ) 2024-05-02 |
Last Dividend | $0.0350 ( 2023-11-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 25.04 |
ATR14 | $0.109 (1.81%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Fife Steven R | Buy | 3 232 | Common Stock |
2024-04-01 | Fife Steven R | Buy | 17 002 | Common Stock |
2024-04-01 | Fife Steven R | Sell | 15 107 | Common Stock |
2024-04-01 | Fife Steven R | Sell | 17 002 | Performance Stock Units |
2024-04-01 | Fife Steven R | Sell | 3 232 | Performance Stock Units |
INSIDER POWER |
---|
27.39 |
Last 100 transactions |
Buy: 1 077 225 | Sell: 570 375 |
ボリューム 相関
LifeVantage Corp 相関
10 最も負の相関 | |
---|---|
ORTX | -0.9 |
ALBO | -0.899 |
DRNA | -0.891 |
AAON | -0.89 |
CMPI | -0.887 |
CNST | -0.872 |
BLCT | -0.871 |
PLPC | -0.867 |
ASLN | -0.865 |
CNCE | -0.865 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
LifeVantage Corp 相関 - 通貨/商品
LifeVantage Corp 財務諸表
Annual | 2023 |
収益: | $213.40M |
総利益: | $170.01M (79.67 %) |
EPS: | $0.200 |
FY | 2023 |
収益: | $213.40M |
総利益: | $170.01M (79.67 %) |
EPS: | $0.200 |
FY | 2022 |
収益: | $206.36M |
総利益: | $168.26M (81.54 %) |
EPS: | $0.240 |
FY | 2021 |
収益: | $220.18M |
総利益: | $181.99M (82.66 %) |
EPS: | $0.920 |
Financial Reports:
No articles found.
LifeVantage Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0300 (N/A) |
$0.0300 (N/A) |
$0.0300 (N/A) |
$0.0350 (N/A) |
$0.435 (N/A) |
$0.0350 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0300 | 2022-05-16 |
Last Dividend | $0.0350 | 2023-11-30 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 7 | -- |
Total Paid Out | $0.625 | -- |
Avg. Dividend % Per Year | 4.96% | -- |
Score | 5.72 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.65 | |
Div. Directional Score | 7.21 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $0.0900 | 1.35% |
2023 | $0.535 | 14.20% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0140 | 1.500 | 9.72 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0472 | 1.200 | 8.43 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0950 | 1.500 | -0.0557 | -0.0836 | [0.1 - 1] |
payoutRatioTTM | 2.30 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.680 | 0.800 | 6.60 | 5.28 | [1 - 3] |
quickRatioTTM | 0.865 | 0.800 | 9.62 | 7.70 | [0.8 - 2.5] |
cashRatioTTM | 0.753 | 1.500 | 6.93 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.220 | -1.500 | 6.34 | -9.50 | [0 - 0.6] |
interestCoverageTTM | 14.01 | 1.000 | 5.92 | 5.92 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.088 | 2.00 | 9.64 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.836 | 2.00 | 9.58 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.505 | -1.500 | 7.98 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.796 | 1.000 | 0.0587 | 0.0587 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0110 | 1.000 | -1.780 | -1.780 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.996 | 1.000 | 5.58 | 5.58 | [0.2 - 2] |
assetTurnoverTTM | 3.37 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 10.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 26.34 | 1.000 | 7.44 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0950 | 2.50 | -0.0358 | -0.0836 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.836 | 2.00 | 9.72 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 8.73 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.088 | 2.00 | 9.64 | 10.00 | [0 - 30] |
payoutRatioTTM | 2.30 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -0.760 | 1.500 | -8.40 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0651 | 1.000 | -0.873 | 0 | [0.1 - 0.5] |
Total Score | 3.65 |
LifeVantage Corp
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。